A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report

Relapsed/refractory ovarian cancer, especially platinum resistance recurrence, remains a major therapeutic challenge. Here, we present the case of a patient with recurrent ovarian clear cell carcinoma (OCCC) who failed to respond to multiline chemotherapy and target therapy but achieved an immune co...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xukai, Sun, Yating, Li, Jiajia, Jiang, Qidi, Yuan, Lei, Li, Ting, Chen, Mo, Yao, Liangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582938/
https://www.ncbi.nlm.nih.gov/pubmed/36275748
http://dx.doi.org/10.3389/fimmu.2022.951422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582938/
https://www.ncbi.nlm.nih.gov/pubmed/36275748
http://dx.doi.org/10.3389/fimmu.2022.951422

Ejemplares similares